Vampt America, Inc.
CIK:0001365022|SEC Filings
|
Consolidated Statements of Operations (Unaudited) (USD $)
|
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
|
Sep. 30, 2012
|
Sep. 30, 2011
|
Sep. 30, 2012
|
Sep. 30, 2011
|
|
| Consolidated Statements Of Operations [Abstract] | ||||
| Revenue | $ 65,982 | $ 58,095 | $ 131,491 | $ 442,552 |
| Cost of goods sold | 96,940 | 185,454 | 179,770 | 543,214 |
| Gross Profit (Loss) | (30,958) | (127,359) | (48,279) | (100,662) |
| Expenses | ||||
| Compensation and benefits | 302,982 | 149,069 | 720,702 | 360,672 |
| General and administrative | 27,702 | 39,631 | 77,839 | 55,611 |
| Product research and development | 36,225 | 37,565 | ||
| Professional fees | 451,905 | 31,184 | 974,284 | 78,192 |
| Sales and marketing | 161,342 | 301,095 | 346,616 | 418,006 |
| Travel | 47,892 | 52,987 | 134,335 | 121,365 |
| Operating expenses total | 991,823 | 610,191 | 2,253,776 | 1,071,411 |
| Other Income (Expense) | ||||
| Loss on extinguishment of debt | (457,777) | |||
| Gain on derivative liability | 938 | 2,061 | ||
| Interest expense | (64,369) | (6,226) | (148,250) | (6,226) |
| Net loss | $ (1,086,212) | $ (743,776) | $ (2,906,021) | $ (1,178,299) |
| Basic and diluted loss per common share | $ (0.04) | $ (0.15) | ||
| Weighted average number of common shares outstanding | 24,221,680 | 18,883,090 | ||